Option Agreement
Beyond's analysis on Option Agreement
- — Abogen’s mRNA T‑cell engager deal with Novartis expands immunotherapy pipeline and validates its RNA platform
- — Abogen licenses its mRNA-encoded T-cell engager to Novartis, expanding the latter's immuno-oncology pipeline
Recent news mentioning Option Agreement
- — Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs
- — Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs
- — Big Bear Gold Corp. Signs Assignment and Assumption of Property Option Agreement to Acquire 100% Optioned Interest in Peerless Property
- — Brixton Metals Enters into Option Agreement to Acquire a 100% Interest in the Silver Focused Silvergruvan Project in Sweden
- — Trident Closes Option Agreement with Apogee Minerals on the Knife Lake Copper Project, Saskatchewan
- — A.I.S. Resources Provides Update on Frenchmans Creek and Grand Bay Option Agreement